Fortress Biotech, Inc.
FBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $42 | $24 | $59 | $204 |
| - Cash | $57 | $81 | $178 | $306 |
| + Debt | $76 | $89 | $127 | $75 |
| Enterprise Value | $61 | $32 | $8 | -$27 |
| Revenue | $58 | $85 | $76 | $69 |
| % Growth | -31.8% | 11.6% | 10.1% | – |
| Gross Profit | $37 | $62 | $45 | $37 |
| % Margin | 63.8% | 72.9% | 59.4% | 53.4% |
| EBITDA | -$104 | -$136 | -$194 | -$146 |
| % Margin | -181.2% | -160.6% | -255.7% | -212.5% |
| Net Income | -$46 | -$61 | -$87 | -$65 |
| % Margin | -79.8% | -71.7% | -114.3% | -94.1% |
| EPS Diluted | -2.69 | -8.47 | -14.55 | -11.85 |
| % Growth | 68.2% | 41.8% | -22.8% | – |
| Operating Cash Flow | -$80 | -$128 | -$179 | -$117 |
| Capital Expenditures | -$15 | -$8 | -$3 | -$16 |
| Free Cash Flow | -$95 | -$136 | -$182 | -$133 |